52‐4: Metasurface‐Integrated Augmented Reality Waveguide Enabled by Resolution Enhancement Technology in KrF Photolithography
SID Symposium Digest of Technical Papers · 2026-06 · 57 (1) · 725-728
DOI: 10.1002/sdtp.70001_199 ↗Kurz gefasst
Fachartikel in der Zeitschrift SID Symposium Digest of Technical Papers, online erschienen am 11.09.2026. Verfasst von Kuan-Lin Lee und 5 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
This paper introduces optical proximity correction and double patterning to realize metasurface‐integrated Augmented Reality (AR) waveguides by KrF photolithography. We demonstrate apodised 2D exit‐pupil‐expander structures to enhance image uniformity with a wide field of view and large eye‐box, dual‐focal waveguide metalenses addressing vergence‐accommodation conflict (VAC), and metagratings to boost in‐coupling efficiency and reduce eye glow. These results highlight a scalable, cost‐ effective approach for manufacturing advanced metasurfaces for next‐generation near‐eye displays.
Zitieren
APA
Lee, K., Sung, S., Wu, C., Li, P., Liang, W., & Yu, P. (2026). 52‐4: Metasurface‐Integrated Augmented Reality Waveguide Enabled by Resolution Enhancement Technology in KrF Photolithography. SID Symposium Digest of Technical Papers, 57(1), 725-728. https://doi.org/10.1002/sdtp.70001_199
Vancouver
Lee K, Sung S, Wu C, Li P, Liang W, Yu P. 52‐4: Metasurface‐Integrated Augmented Reality Waveguide Enabled by Resolution Enhancement Technology in KrF Photolithography. SID Symposium Digest of Technical Papers. 2026;57(1):725-728. doi:10.1002/sdtp.70001_199
BibTeX
@article{Lee2026,
author = {Lee, Kuan-Lin and Sung, Shang-Chiang and Wu, Chih-Han and Li, Ping-Ke and Liang, Wen-Teng and Yu, Peichen},
title = {52‐4: Metasurface‐Integrated Augmented Reality Waveguide Enabled by Resolution Enhancement Technology in KrF Photolithography},
journal = {SID Symposium Digest of Technical Papers},
year = {2026},
volume = {57},
number = {1},
pages = {725--728},
doi = {10.1002/sdtp.70001_199}
}
EUVIMED